Delivery Order SPE2DR25D2006-SPE2DR26F57HL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,189.06 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60 count) under a firm fixed price contract. The order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Rifampin 300 mg capsules in quantities of 60 units, with a ceiling value of $6,960.94 and an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order structure and represents a task order under the company's broader pharmaceutical supply agreement with DLA Troop Support Medical. The place...
- The Defense Logistics Agency awarded a $6.82K delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rifampin 300 mg capsules (60-count). The contract, which carries a firm fixed price and requires completion by December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $12,685.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on a firm fixed-price basis. The contract, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $2,655.95 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed price contract. The order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $6,675.68. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.21 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $29,013.01 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,464.47. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established relationship with...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57HLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,928.15 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, syringes, vials, and test kits. The delivery order reflects the company's ongoing role in fulfilling essential pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 1/12/26 |